M. Inoue et al., IMPAIRED EXPRESSION OF ATRIAL-NATRIURETIC-PEPTIDE IN DIABETIC RATS WITH MYOCARDIAL-INFARCTION, Research communications in molecular pathology and pharmacology, 100(3), 1998, pp. 327-338
We evaluated the effects of myocardial infarction (MT) on the hemodyna
mics and the expression of atrial natriuretic peptide (ANP) mRNA in ra
ts with streptozotocin-induced diabetes. Eight weeks after streptozoto
cin injection, the diabetic rats and age-matched nondiabetic controls
underwent coronary artery ligation. One week later, the left ventricul
ar end-diastolic pressure, systolic blood pressure, infarct size, and
serum ANP levels did not differ significantly between the diabetic and
nondiabetic rats. Compared with control animals without MI, the atria
l ANP/beta-actin mRNA ratio in rats with MI was increased to 195% in d
iabetic animals and 213% in nondiabetic animals. In the left ventricle
, however, the ANP/beta-actin mRNA ratio in diabetic animals with MI w
as increased to only 131% compared with control animals, whereas the c
orresponding increase in nondiabetic animals was 240% (p<0.05). Thus,
the modulation of ANP mRNA expression after MI was impaired in the lef
t ventricle, but not in the atria, of diabetic rats. A reduced myocard
ial expression of ANP could increase the morbidity and mortality assoc
iated with cardiovascular disorders in patients with diabetes.